Medtronic, Inc. Stock Nyse
Equities
US5850551061
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- USD | - |
Apr. 17 | Baird Adjusts Medtronic Price Target to $88 From $91 | MT |
Apr. 15 | Integer Holdings to Benefit from Pulsed Field Ablation Market Growth, BofA Says | MT |
Financials (USD)
Sales 2024 * | 32.24B | Sales 2025 * | 33.58B | Capitalization | 105B |
---|---|---|---|---|---|
Net income 2024 * | 4.55B | Net income 2025 * | 5.24B | EV / Sales 2024 * | 3.95 x |
Net Debt 2024 * | 22.3B | Net Debt 2025 * | 21.07B | EV / Sales 2025 * | 3.75 x |
P/E ratio 2024 * |
22.6
x | P/E ratio 2025 * |
19.6
x | Employees | - |
Yield 2024 * |
3.48% | Yield 2025 * |
3.66% | Free-Float | 99.82% |
Latest transcript on Medtronic, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Geoffrey Martha
CEO | Chief Executive Officer | 54 | 15-01-25 |
Karen Parkhill
DFI | Director of Finance/CFO | 58 | 16-05-31 |
Gregory Smith
COO | Chief Operating Officer | 60 | 21-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Scott Donnelly
BRD | Director/Board Member | 62 | 12-12-31 |
Kendall Powell
BRD | Director/Board Member | 70 | 06-12-31 |
Randall Hogan
BRD | Director/Board Member | 68 | 14-12-31 |
1st Jan change | Capi. | |
---|---|---|
-4.77% | 67.09B | |
+7.87% | 51.61B | |
+16.18% | 47.55B | |
+0.85% | 39.95B | |
+7.17% | 27.62B | |
-1.23% | 25.62B | |
+3.80% | 25.74B | |
+11.68% | 24.93B | |
-0.33% | 24.92B |